Artificial intelligence and machine learning in drug discovery: From lead discovery to clinical validation (2020–2025)
December 2025
Artificial intelligence (AI) and machine learning (ML) are fundamentally changing the small-molecule drug discovery process, primarily by moving the workflow from being empirically screened to data-driven,...
Alkylating agents in cancer: Current developments
December 2025
The term cancer is derived from a Latin word “cancrum” which means crabs, and associated with group of disease which is related with cellular malfunctions. It is one of the major causes of death in...
Pharmacological treatment of adolescent depression: Current advances and future perspectives
December 2025
Adolescent depression is a prevalent and increasingly concerning mental health condition, characterized by persistent low mood, loss of interest, and impaired social functioning. Due to the complexity...
AI in forensic toxicology: Machine learning for detection, classification, and prediction of Illicit substances
September 2026
Artificial intelligence (AI) and machine learning (ML) are increasingly transforming forensic toxicology by improving the detection, classification, and interpretation of illicit substances. Conventional...
Phytochemicals as promising lead compounds for drug discovery: A comprehensive review of mechanisms and pharmacological potentials
January 2026
Phytochemicals, bioactive compounds derived from medicinal plants, have long contributed to drug discovery by providing diverse chemical scaffolds and broad biological activities. Despite strong preclinical...
Nanotechnology-enabled pharmaceuticals and biomaterials: Innovations in drug delivery, theranostics, and clinical translation
July 2026
Nanotechnology has transformed modern medicine by addressing critical challenges in drug delivery, diagnostics, and biomaterials engineering. The integration of nanoscale materials into pharmaceutical...
Antiviral agents: A journey through time to discover new uses and advancements
April 2026
Viruses are microscopic infectious agents composed of nucleic acid enclosed within a protein coat and are not visible to the naked eye. Viral infections, including those caused by HIV, influenza, respiratory...
Nanotechnology-enhanced herbal sunscreens: A natural approach to UV protection and skin care
January 2026
Prolonged exposure to ultraviolet (UV) radiation is a leading cause of several skin-related concerns, including sunburn, premature aging, pigmentation, and even skin cancer. While conventional sunscreens...
An update on the role of inflammation in insulin resistance and islet β cell failure- A crosstalk between immune cells, adipose tissue, cytokines, and oxidative stress
March 2025
One of the characteristics of type 2 diabetes mellitus (T2DM) is the growing malfunctioning of β-cells and the presence of insulin resistance. The recent literature on this aspect is reviewed in this...
Firsekibart, an IL-1β inhibitor, for the treatment of refractory acute gout in an elderly patient with multimorbidity: A case report
July 2026
Refractory acute gout in elderly patients with multimorbidity is difficult to manage because standard anti-inflammatory therapies, including nonsteroidal anti-inflammatory drugs, colchicine, and glucocorticoids,...
Spray on science: Revolutionizing topical drug delivery with film-forming systems
March 2026
Film-forming sprays (FFS) have emerged as advanced topical and transdermal drug delivery systems offering improved drug retention, enhanced bioavailability, and better patient compliance compared to...
Benzimidazole derivatives as anticancer agents: A review of recent literature and structure-activity relationships
November 2025
The structural diversity and associated biological activities of benzimidazole derivatives have made them attractive to medicinal chemists. Due to diverse biological activities of benzimidazole derivatives,...
Antimicrobial resistance: Emerging challenges, prevention approaches, and the critical need for new drug development
August 2026
Antimicrobial resistance (AMR) is a major global health challenge that compromises the effectiveness of antimicrobial therapy and accelerates the emergence of multidrug-resistant bacterial infections....
Regulation of hyperglycemia in type 2 diabetes mellitus: Insights into current therapeutic pathways
October 2025
Diabetes mellitus (DM) has emerged as a rapidly growing global health challenge, affecting millions of people worldwide and posing a significant socio-economic burden on healthcare systems in both developing...
Antigen–antibody interactions in precision medicine: Molecular mechanisms, targeted drug delivery, and nanomedicine applications
May 2026
Conventional systemic drug administration remains constrained by non-specific tissue distribution and dose-limiting toxicity, which necessitates the development of precision-guided therapeutic alternatives....
Quality by design based analytical (RP-HPLC) method development and validation of coenzyme q10 in single and combination with clomiphene citrate: An extensive review
November 2025
Analytical Quality by Design (AQbD) has emerged as a rigorous, science-driven framework that supports the development of robust and regulatory-compliant analytical procedures. Its application to RP-HPLC...
The effects of hydrogen-rich water on gut microbiota and related health outcomes: A systematic review
September 2025
Hydrogen-rich water (HRW) has emerged as a promising therapeutic intervention due to its antioxidant and anti-inflammatory properties. Recent studies suggest that the ingestion of HRW may alter gut...
Evaluation of the medicinal properties of Solanum nigrum L.: A composite herb with potential health benefits
April 2026
Solanum nigrum L., a potent medicinal herb commonly known as Makoi or black nightshade, belongs to the family Solanaceae, exhibiting wider distribution from tropics to temperate....
AI-driven target discovery and clinical development of candidate drugs for idiopathic pulmonary fibrosis: A review
October 2025
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease with high mortality and limited treatment options, urgently requiring new therapeutic targets and drug development strategies. In recent...
Combating antimicrobial resistance: Exploring new scaffolds and mechanistic insights
June 2026
Antimicrobial resistance (AMR) has emerged as a critical global health threat, compromising the effectiveness of existing antimicrobial therapies and contributing to increased morbidity, mortality,...
Human microbiome-driven antimicrobial resistance: Biological mechanisms, pharmacological considerations and next-generation therapeutic prospects
March 2026
Antimicrobial resistance (AMR) remains a serious global health challenge, threatening the effectiveness of existing antimicrobial therapies. Although resistance has traditionally been linked to antibiotic...
Formulation and optimization of Kaempferol nanoemulsion-based gel for treating skin erythema using Box-Behnken statistical design
August 2025
The objective of this study is to develop and characterize Kaempferol (KMF)-loaded nanoemulsion-based gel formulations for the treatment of skin erythema. A Box-Behnken design was utilized to optimize...
Novel bis-pyrano[2,3-c]pyrazoles as potential antidiabetic agents: Synthesis, biological evaluation, and computational insights
June 2026
Type 2 diabetes mellitus (T2DM) remains a major global health concern, necessitating the development of safer and more effective therapeutic agents. Pyrano[2,3-c]pyrazole derivatives have emerged as...
Quality by design-based development and validation of a robust RP-HPLC method for the simultaneous estimation of nirmatrelvir and ritonavir in pharmaceutical formulations
December 2025
The current research sought to design and evaluate a robust, risk-based HPLC technique for the simultaneous quantification of Nir (Nir) and Ritonavir (Rit) in pharmaceutical formulations, using a Quality...
Computational and experimental investigation of propofol- and remifentanil-associated immunometabolic modulation through amino acid transporters and AMPK–mTOR signaling in macrophages
August 2026
Propofol and remifentanil, commonly used intravenous anesthetics, exert immunomodulatory effects that may influence perioperative immune responses. Macrophage immunometabolism, governed by amino acid...